InvestorsHub Logo
Followers 0
Posts 165
Boards Moderated 0
Alias Born 11/22/2022

Re: vinmantoo post# 2350

Thursday, 11/24/2022 8:59:56 AM

Thursday, November 24, 2022 8:59:56 AM

Post# of 2983
For laughs? Not trying to laugh. Just trying to be objective. And I’m not short anything.

A good example for you is any of the RSV therapeutics- all failed. Great exposures and great potencies - no translation. My point is that just because something is potent and has good PK, that doesn’t mean it will translate into a cure for an acute infection. Remember, this is a phase 2 in standard risk, highly seropositive population with a safety primary endpoint. A very hesitant step, you must agree.

Yes this is a validated MoA. But, they are not showing their full hand. Again- where is the animal efficacy data? They must have it. Everyone else has shown this. If someone was buying, they would have already bought it. Certainly cheap enough here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News